Isotopia Molecular Imaging begins clinical supply collaboration with Y-mAbs Therapeutics, Inc. Read more
NanOlogy Enrolls First Patient in Phase 2 Clinical Trial of NanoPac for Intratumoral Treatment of Prostate Cancer Read more
Axsome Therapeutics and Veeva Systems Partner to Build Axsome’s Digital-Centric Commercialization Platform Read more
XNK Therapeutics receives US orphan drug status for NK cell-based immunotherapy in multiple myeloma Read more
Bristol Myers Squibb Announces Deucravacitinib (BMS-986165) Demonstrated Superiority to Placebo and Otezla (apremilast) in Pivotal Phase 3 Psoriasis Study Read more
Ionis and Akcea announce that Pfizer has initiated a Phase 2b clinical study of vupanorsen (AKCEA-ANGPTL3-LRx) Read more
GW Pharmaceuticals Initiates Pivotal Phase 3 Study of Nabiximols for Multiple Sclerosis-Associated Spasticity Read more
PerkinElmer to Acquire Cell Engineering Company Horizon Discovery for $383 Million (£296 Million) Read more
EC approves Roche’s Tecentriq in combination with Avastin for the treatment of people with the most common form of liver cancer Read more